OverviewChartNewsTraderScreen

UniCredit Call 65 BRM 19.06.2024/  DE000HC544Y7  /

Frankfurt Zert./HVB
09/05/2024  13:23:03 Chg.0.000 Bid15:51:28 Ask- Underlying Strike price Expiration date Option type
0.001EUR 0.00% -
Bid Size: -		 -
Ask Size: -		 BRISTOL-MYERS SQUIBB... 65.00 - 19/06/2024 Call
GlobeNewswire 21/05 Purple Biotech Reports First Quarter 2024 Financial Results
GlobeNewswire 16/05 CytomX Therapeutics Announces New Employment Inducement Grants
GlobeNewswire 15/05 Lantheus Announces Executive Appointments to Accelerate Innovation
GlobeNewswire 14/05 Firefly Neuroscience, an AI-Driven Brain Health Company, Appoints Healthcare-Industry Executive, Dav...
GlobeNewswire 14/05 Nouscom Appoints Leading Cancer Drug Development Expert, Neil Gallagher, MD, PhD, as Independent Adv...
GlobeNewswire 13/05 Ikena Oncology Reports First Quarter 2024 Financial Results and Corporate Update
GlobeNewswire 08/05 CytomX Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 08/05 Immunocore reports first quarter financial results and provides a business update
GlobeNewswire 07/05 CytomX Therapeutics Announces Clinical Collaboration with Merck to Evaluate CX-801 in Combination wi...
GlobeNewswire 02/05 Vor Bio Appoints Accomplished Oncology and Cancer Immunotherapy R&D Executive, Fouad Namouni, M.D., ...
GlobeNewswire 01/05 Editas Medicine and Bristol Myers Squibb Extend Alpha-Beta T Cell Collaboration
GlobeNewswire 01/05 CytomX Therapeutics to Report First Quarter 2024 Results and Provide an Initial CX-904 Phase 1a Clin...
GlobeNewswire 30/04 Akero Therapeutics Appoints Scott Gangloff as Chief Technology Officer
GlobeNewswire 30/04 CHARM Therapeutics appoints Dr Nicholas Edmunds as Chief Development Officer, Head of Pre-Clinical D...
GlobeNewswire 25/04 International Myeloma Foundation Holds 15th Annual Gala at the Edison Ballroom in New York City on A...
GlobeNewswire 25/04 Purple Biotech's Randomized Phase 2 CM24 Pancreatic Cancer Study Selected as Late-Breaking Abstract ...
GlobeNewswire 25/04 Nucleome Therapeutics appoints Dr John Davis as Non-Executive Director of the Board and establishes ...
GlobeNewswire 22/04 ArriVent Appoints Kristine Peterson to its Board of Directors
GlobeNewswire 08/04 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Bristol-Myers Sq...
GlobeNewswire 08/04 Dr. Chi Li Joins Curevo Vaccine as Chief Regulatory Officer
GlobeNewswire 08/04 TScan Therapeutics Appoints Seasoned Hematology and Oncology Expert Chrystal U. Louis, M.D., M.P.H.,...
GlobeNewswire 08/04 CytomX Therapeutics Announces First Patient Dosed with CX-2051, a Conditionally Activated EpCAM-Dire...
GlobeNewswire 05/04 Akoya Biosciences Showcases Spatial Biology 2.0 Solutions at AACR Annual Meeting with Case Studies D...
GlobeNewswire 03/04 Standard BioTools Announces Multi-Year Strategic Engagement with Bristol Myers Squibb for Use of the...
GlobeNewswire 03/04 CytomX Therapeutics Announces Nomination of Second Clinical Candidate in Broad PROBODY® T-Cell Engag...